Posted by Administrator on April 12th, 2006 — in Ultram News
Friday, rising 21% after the company said the Food and Drug Administration approved its Tramadol ER painkiller. http://www.drugonline.cc
The painkiller was approved for the treatment of moderate to moderately severe chronic pain in 100 milligram, 200 milligram and 300 milligram dosage strengths. Biovail, it said, is the only company to submit an application to the FDA […]
No Comments »
Posted by Administrator on April 12th, 2006 — in Ultram News
A new prescription option is now available to the more than 50 million Americans who suffer from moderate to moderately severe chronic pain. Ortho-McNeil, Inc., and Biovail Corporation (NYSE, TSE: BVF) today announced that once-daily ULTRAM® ER (tramadol HCl) extended-release tablets are now available by prescription in the United States.
ULTRAM® ER is the first […]
No Comments »